Author
Thomas Jefferson UniversityORCID 0000-0003-0203-9171Unclaimed ORCID profile · follow to get notified of new preprints
3 papers
Recent·Most cited
Michael Ortiz, Charlie B. Ffrench, Stuart Webb…·Claudine S. Bonder
This study identifies TPD54 as a regulator of protein trafficking in melanoma, showing its role in disease progression and potential as a therapeutic target.
Kylie E Preihs, Kübra Karagoz, Claire R Shuey…·My G Mahoney
This paper identifies EV-associated cytokines as mediators of IVIg activity, showing that engineered IFNγ-eEVs can suppress IFNγ signaling through context-dependent mechanisms.
Priyan Bhattacharya, Alban J. Linnenbach, Andrew P. South…·Rajanikanth Vadigepalli
This study develops a computational model of the HNSCC tumor microenvironment to identify subtype-specific resistance mechanisms and predict therapeutic targets for immunotherapy.